Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by floatinketucky


V.TLT

$TLTFF Patent To Destroy Cancer Cells With X-Ray

Theralase® Granted United States Patent To Destroy Cancer Cells With X...

February 8, 2022

V.TLT

RE:Photo Dynamic Compound Inactivation of SARS-CoV-2 Vaccine

Theralase® Demonstrates Proof-of-Concept for Canadian-Made COVID-19...

February 8, 2022

V.TLT

As of November 29, 2021,

Study II Preliminary Results As of November 29, 2021, Study II has...

February 8, 2022

V.TLT

Leadership transition. Quality Control Validated!!

Effective October 25, 2021, Vera Madzarevic, Ph.D. assumed the role of...

February 8, 2022

V.TLT

RE:RE:RE:RE:Theralase made the announcement because its relevant.

floatinketucky wrote: Good point. I think there was never confusion that...

February 8, 2022

V.TLT

%TLTFF 1ST GEAR ITS ALLRIGHT!!

{^youtubevideo|(width)425|(height)264|(rel)False|(url)https://www.youtube.com...

February 8, 2022

V.TLT

RE:$TLTFF 67% CR ON ONE TREATMENT FULL DOSE

The little deuce coup of NMIBC non response. {^youtubevideo|(width)425...

February 8, 2022

V.TLT

$TLTFF The market is seeing the value. Validation continues

$TLTFF Continues to validate the science and processes.   GOLD...

February 8, 2022

V.TLT

$TLTFF ADDITIONAL CANCER RESEARCH. pst hey buddy... shhhhhhh

they have their own lab now and are working their a$$ off. They are building...

February 8, 2022

V.TLT

Have we left the newsletters?

Mabye more PRs are on the way?

February 7, 2022

V.TLT

$TLTFF RESEARCH VALIDATED. ON TO THE NEXT STEP!

Nice progress guys!! With ORF and the Canadian Gov backing the play we are on...

February 7, 2022

V.TLT

$TLTFF - AA BTD safety and CR rates. Hello Darlin.

Theralase is the New FDA Darlin SES* was the FDA NMIBC darling but they...

February 5, 2022

V.TLT

$TLTFF

Beethoven/Liszt - Symphony 5 1st Movement (25k subs special) - YouTube...

February 5, 2022

V.TLT

$TLTFF NMIBC NONRESPONSE FIRST IN CLASS.

                      ...

February 4, 2022

V.TLT

RE:TOP 6 Most Viewed

OVER 42 THOUWOW.. DAT A RECORD BREAKER DOC!!!{^youtubevideo|(width)425...

February 3, 2022

V.TLT

$TLTFF NMIBC NONRESPONSE FIRST IN CLASS.

The gold standard for NMIBC.  The brightested light on the darkest...

February 3, 2022

V.TLT

#jimcrammer NMIBC NONRESPONSE FIRST IN CLASS.

#jimcrammer Theralase has revenue! New FAST LANE CAR for first in class NMIBC...

February 3, 2022

V.TLT

They were excited for NMIBC at SESN First in class? NOT!!!

The Company was looking at a major catalyst in 2021, the approval of Vicineum...

February 3, 2022

V.TLT

70 percet and less dossed patients.

$TLTFF I'm expecting the number to come up slowly. The first dozen...

February 3, 2022

V.TLT

Photo Dynamic Compound Inactivation of SARS-CoV-2 Vaccine

Under the terms of the agreement, Theralase® and Public Health...

February 3, 2022

Featured Company